{"id":"NCT04873232","sponsor":"Helixmith Co., Ltd.","briefTitle":"A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy","officialTitle":"A 6-Month Extension Study Following Protocol VMDN-003-2 - An Adaptive, Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-05-17","primaryCompletion":"2023-09-14","completion":"2024-07-23","firstPosted":"2021-05-05","resultsPosted":"2025-01-16","lastUpdate":"2025-01-16"},"enrollment":106,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Peripheral Neuropathy"],"interventions":[{"type":"BIOLOGICAL","name":"Engensis","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Engensis","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the durability of efficacy and long-term safety of intramuscular administration of Engensis or Placebo that was administered in the double-blind, randomized, VMDN-003-2 Placebo-controlled Phase 3 Study.","primaryOutcome":{"measure":"To Evaluate the Efficacy of Intramuscular Administration of Engensis on Reducing Pain in Participants With Painful Diabetic Peripheral Neuropathy in the Feet and Lower Legs as Compared to Placebo","timeFrame":"From the 7 days prior to the Day 0 Visit (Study VMDN-003-2, NCT04469270), Day 270, to the 7 days prior to the Day 365 Visit in the intent-to-treat population","effectByArm":[{"arm":"Engensis","deltaMin":-2.27,"sd":2.083},{"arm":"Placebo","deltaMin":-2.62,"sd":2.087}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":16,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":49},"commonTop":["COVID-19","Influenza","Diabetic retinopathy","Lipase increased","Diabetes mellitus inadequate control"]}}